logo

For the Inventor, By the Inventor

Arlington, VA, United States of America

Chetana M Revankar

This inventor holds 2 USPTO granted patents. Top assignee: The University of New Mexico. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chetana M Revankar. Retrieved from https://idiyas.com/inventor/chetana-m-revankar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal2 out of 943 
 
The University of New Mexico
 patents

Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents
1. 8487100 - Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof (2013-07-16),
2. 7875721 - Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof (2011-01-25),

Title: Chetana M Revankar: Innovator in Molecular Biology and Pharmacology

Introduction

Chetana M Revankar is a prominent inventor based in Arlington, VA (US). She has made significant contributions to the field of molecular biology and pharmacology, particularly through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing compounds that interact with estrogen receptors and GPR30, which are crucial in treating various disease states.

Latest Patents

Revankar's latest patents include groundbreaking compounds designed for binding to estrogen receptors alpha (ERα), beta (ERβ), and GPR30. These compounds are aimed at modulating the effects of these receptors, which play a vital role in numerous health conditions. The inventions address a wide range of diseases, including various cancers, reproductive disorders, cardiovascular conditions, and neurodegenerative diseases. Additionally, her work includes contraceptive applications to prevent or reduce the likelihood of pregnancy after intercourse.

Career Highlights

Chetana M Revankar has established herself as a leading figure in her field through her innovative research and dedication to improving health outcomes. Her work has the potential to impact the treatment of hormone-dependent cancers, reproductive health issues, and various neurological disorders.

Collaborations

Revankar has collaborated with notable colleagues, including Eric R Prossnitz and Sergey E Tkatchenko, further enhancing the scope and impact of her research.

Conclusion

Chetana M Revankar's contributions to molecular biology and pharmacology exemplify the importance of innovation in addressing complex health challenges. Her patented inventions hold promise for advancing treatment options and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…